Planning Committee

Peter Bulova, MD, Professor of Medicine, Division of General Internal Medicine, University of Pittsburgh Medical Center

Brian Chicoine, MD, Medical Director, Advocate Medical Group Adult Down Syndrome Center; Faculty, Lutheran General Hospital Family Medicine Residency

Laura Cifra-Bean, MD, Down Syndrome Association of Northeast Ohio

Shannon Fizzell, MS, RD, LDN, Clinical Dietitian, Adult Down Syndrome Center of Western Pennsylvania

Laura Krohn, Advocate Medical Group Adult Down Syndrome Center

Lina Patel, PsyD, Associate Professor of Psychiatry, University of Colorado School of Medicine, Aurora, Colorado

Emilie Perkins, Director of Client and Conference Services, Raybourn Group International

Moya Peterson, PhD, APRN, FNP-BC, Adults with Down Syndrome Specialty Clinic, Department of Family Medicine and Community Health, University of Kansas Medical Center

Mary Pipan, MD, University of Pennsylvania School of Medicine

Karin Roseman, LSW, Jefferson Continuing Care Program

Maria Stanley, MD, FAAP, Clinical Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health; Medical Director, Waisman Center; Director, Down Syndrome Clinic

Pat Zidek, RN, Advocate Aurora Health, Adult Down Syndrome Clinic

Program Presenters

Thessa Hilgenkamp, PhD, Assistant Professor and Director of the Cardiovascular Research and Exercise Lab, Department of Physical Therapy, University of Nevada, Las Vegas

Sarah Mann, PT, DPT, MBA, NSCA-CPT, Doctor of Physical Therapy in Arvada, Colorado

Policy on Faculty and Sponsor Disclosure

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate, and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.